Combination of betulinic acid with cisplatin - Different cytotoxic effects in two head and neck cancer cell lines

Oncology Reports

Volumn 14, Issue 3, 2005, Pages 667-671

  Eder Czembirek, Christina ^a   Czembirek, Cornelia ^a   Erovic, Boban M ^a   Selzer, Edgar ^a   Turhani, Dritan ^a   Vormittag, Laurenz ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Betulinic acid; Caspases; Cisplatin; Head and neck cancer; Mcl 1

Indexed keywords

ANTINEOPLASTIC AGENT; BETULIC ACID; CASPASE; CISPLATIN; MCL1 PROTEIN; PROTEIN BCL 2; TRITERPENE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TRITERPENES;

EID: 24644520835     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.3.667     Document Type: Article

References (14)

1. Pisha E, Chai H, Lee IS, et al: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1: 1046-1051, 1995.
2. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B and Kodym R: Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 114: 935-940, 2000. (Pubitemid 30252714)
3. Fulda S, Jeremias I, Pietsch T and Debatin KM: Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr 211: 319-322, 1999. (Pubitemid 29364776)
4. Thurnher D, Turhani D, Pelzmann M, et al: Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells. Head Neck 25: 732-740, 2003. (Pubitemid 37034260)
5. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME and Debatin KM: Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273: 33942-33948, 1998. (Pubitemid 29008858)
6. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997. (Pubitemid 27508237)
7. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S: A caspase-activated DNAase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50, 1998. (Pubitemid 28079208)
8. MacFarlane M, Merrison W, Dinsdale D and Cohen GM: Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148: 1239-1254, 2000.
9. Leers MP, Kölgen W, Björklund V, et al: Immunocytochemical detection and mapping; of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187: 567-572, 1999. (Pubitemid 29151999)
10. Aapro MS, Alberts DS and Salmon SE: Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. Cancer Chemother Pharmacol 10: 161-166, 1983. (Pubitemid 13028312)
11. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
12. Fulda S, Friesen C, Los M, et al: Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via acitivation of caspases in neuroectodermal tumors. Cancer Res 57: 4956-4964, 1997. (Pubitemid 27469008)
13. Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C and Formelli F: Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175: 17-25, 2002. (Pubitemid 33153040)
14. Pignon JP, Bourhis J, Domenge C and Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355: 949-955, 2000. (Pubitemid 30148259)